Market for stomach pumps is expected to increase at higher rate due to increase in patients having by-pass gastric surgery and an extra obesity issues. Moreover, weight loss stomach pump market is likely to grow at a noteworthy CAGR owing to their capacity to drop the weight of the body with least tactlessness. These pumps are frequently utilized by bulimia nervosa (an eating disorder) patients aging 22 and further. Worldwide upsurge in non-surgical treatments, an increase in obesity and bulimia patients and change in lifestyle habits will correspondingly support the weight loss stomach pump market growth. Nevertheless, side effects accompanied by surgery are firm challenges which might hamper the growth of the market.

The weight loss stomach pump market is bifurcated on the basis of disease type, end-user, and geography. By disease type, the market for weight loss stomach pump is bifurcated into bulimia, anorexia, and diabetes. Unhealthy lifestyle is impelling in growing obesity associated ailments among healthy environment. Therefore, weight loss stomach pump would play a key role in successful control over obesity. By end-users, the market for weight loss stomach pump is bifurcated into hospitals, clinics, nursing homes among others. The weight loss stomach pump suppliers offer specific programs to the end-users supporting in management of health plans by offering solutions to growing costs of complexities during treatment.

In terms of geography the weight loss stomach market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA). North America dominates the market for weight loss stomach pumps owing to the technological development in the region. Countries such as Canada and United states have succeeded in executing weight loss stomach pump in their healthcare structure, which in turn is expected to boost the market for weight loss stomach pumps over the forecast period. Furthermore, presence of favorable government initiatives, improved healthcare infrastructure in implementing weight loss stomach pumps in the existing healthcare organizations will boost the growth of weight loss stomach pumps market. Moreover, persistently improving reimbursement development would further drive the market growth. Europe was perceived to be the second largest market in the weight loss stomach pumps due to improved weight loss therapy in the healthcare infrastructure coupled with the execution of stomach pump, a weight loss device in the region.

The US FDA permitted novel obesity treatment devices in June 2016 such as Aspire Assist System which is appropriate for moderately overweight patients. FDA studied results from a clinical trial of 111 patients treated with AspireAssist and suitable lifestyle therapy. The players operating in the weight loss stomach pump market include Aspire Bariatrics, Inc. (AspireAssist System), snd Apollo Endosurgery, Inc. (ORBERA balloon), among other significant players worldwide.

Market Segmentation

Market by Disease Type

·         Bulimia

·         Anorexia

·         Diabetes

Market by End User

·         Hospitals

·         Clinics

·         Nursing homes

Market by Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Rest of Asia-Pacific

·         Latin America

o    Brazil

o   Chile

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA